— Know what they know.
Not Investment Advice
Also trades as: AMG.DE (XETRA) · $vol 0M · AMGN.TO (TSX) · $vol 0M · 4332.HK (HKSE) · $vol 0M

AMGN NASDAQ

Amgen Inc.
1W: +4.6% 1M: +7.2% 3M: +13.8% YTD: +38.5% 1Y: +56.0% 3Y: +73.4% 5Y: +155.8%
$447.95
+3.32 (+0.75%)
After Hours: $449.16 (+1.21, +0.27%)
Weekly Expected Move ±4.0%
$404 $421 $439 $457 $475
NASDAQ · Healthcare · Drug Manufacturers - General · Tech Score Buy · Power 75 · $240.4B mcap · 539M float · 0.510% daily turnover · Short 58% of daily vol
Credit Risk of going bust: lower than 74% of companies Debt: 19.2% of company value Bonds: $1.31B held by 639 funds, 79 bp over Treasuries → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $7.22 (down 98%), Amgen Inc. would be worth roughly what it owes.
Total debt $57.30B against a stock market value of $240.38B.
Distance to default 8.24 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $31.37B (short-term plus half of long-term), stock volatility 29.5%; Altman Z 2.36. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
58.4 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 19.5%  ·  5Y Avg: 21.5%
Cost Advantage
46
Intangibles
63
Switching Cost
42
Network Effect
65
Scale ★
88
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. AMGN has a Narrow competitive edge (58.4/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Efficient Scale. ROIC of 19.5% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$230
Low
$409
Avg Target
$500
High
Based on 26 analysts since Aug 4, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 22Hold: 16Sell: 3Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$407.26
Analysts27
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-23 Oppenheimer — $450 $480 +30 +7.3% $447.28
2026-10-21 Barclays — $380 $400 +20 -8.9% $438.94
2026-10-13 Guggenheim Vamil Divan $388 $378 -10 -9.5% $417.57
2026-10-12 BMO Capital — $450 $415 -35 -0.2% $415.80
2026-10-12 Wells Fargo — $435 $430 -5 +3.6% $414.87
2026-10-08 RBC Capital — $400 $430 +30 +5.5% $407.57
2026-10-08 Cantor Fitzgerald Carter Gould $400 $440 +40 +6.5% $413.08
2026-10-07 Truist Financial — $325 $380 +55 -8.1% $413.67
2026-09-28 Scotiabank Louise Chen $450 $500 +50 +19.7% $417.71
2026-09-23 Jefferies Akash Tewari $350 $410 +60 -0.1% $410.24
2026-09-17 UBS Michael Yee $420 $430 +10 +13.6% $378.42
2026-09-04 Wells Fargo Mohit Bansal $375 $435 +60 -2.1% $444.12
2026-08-20 Piper Sandler David Amsellem $427 $457 +30 +3.3% $442.36
2026-08-19 Morgan Stanley — $333 $362 +29 -17.8% $440.28
2026-08-19 Argus Research — Initiated $460 — +4.6% $439.95
2026-08-18 Cantor Fitzgerald — $315 $400 +85 -4.6% $419.38
2026-08-18 Mizuho Securities — $303 $352 +49 -16.1% $419.38
2026-08-14 Barclays Emily Field $360 $380 +20 -9.1% $417.84
2026-08-10 Guggenheim Vamil Divan $343 $388 +45 -5.6% $410.94
2026-08-06 Bernstein — $335 $345 +10 -15.4% $407.83
2026-08-05 Scotiabank Louise Chen Initiated $450 — +10.8% $406.25
2026-08-05 Oppenheimer — $400 $450 +50 +15.4% $390.02
2026-08-05 RBC Capital — $360 $400 +40 +2.6% $390.02
2026-08-05 Robert W. Baird Brian Skorney $215 $230 +15 -41.0% $390.02
2026-08-05 Canaccord Genuity Gary Nachman $366 $384 +18 -1.5% $390.02
2026-08-05 BMO Capital Evan Seigerman $400 $450 +50 +15.4% $390.02
2026-07-29 Barclays Emily Field $185 $360 +175 -8.4% $393.10
2026-07-13 UBS — $390 $420 +30 +17.1% $358.68
2026-07-13 Guggenheim — $340 $343 +3 -5.6% $363.39
2026-07-08 Morgan Stanley — $340 $333 -7 -9.5% $368.10
2026-07-01 BMO Capital Evan David Seigerman $372 $400 +28 +10.4% $362.45
2026-06-16 Mizuho Securities Salim Syed $295 $303 +8 -13.6% $350.53
2026-06-09 Morgan Stanley — $332 $340 +8 -1.3% $344.56
2026-06-05 Goldman Sachs — $369 $389 +20 +10.3% $352.62
2026-05-14 Piper Sandler — $432 $427 -5 +26.9% $336.45
2026-05-04 Guggenheim — $351 $340 -11 +3.1% $329.82
2026-05-01 Morgan Stanley — $326 $332 +6 +0.8% $329.31
2026-04-20 Canaccord Genuity — Initiated $366 — +4.5% $350.16
2026-04-10 Morgan Stanley Terence Flynn $309 $326 +17 -7.5% $352.59
2026-04-09 Guggenheim — Initiated $351 — -1.3% $355.60
2026-04-08 Truist Financial — $318 $325 +7 -7.1% $349.81
2026-03-10 Jefferies Akash Tewari $380 $350 -30 -6.2% $373.08
2026-03-05 Leerink Partners David Risinger $267 $355 +88 -3.4% $367.60
2026-02-19 Barclays — $315 $185 -130 -50.7% $375.50
2026-02-19 Wells Fargo — $400 $375 -25 -1.2% $379.73
2026-02-18 Piper Sandler — $381 $432 +51 +15.7% $373.36
2026-02-11 Mizuho Securities — $235 $295 +60 -19.1% $364.65
2026-02-04 RBC Capital — $332 $360 +28 +0.8% $357.29
2026-02-04 Morgan Stanley — $304 $309 +5 -12.2% $351.81
2026-01-29 Oppenheimer — $380 $400 +20 +16.4% $343.57

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+
Oct 27, 2026
DCF
5
ROE
5
ROA
5
D/E
1
P/E
2
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. AMGN receives an overall rating of B+. Strongest factors: DCF (5/5), ROE (5/5), ROA (5/5). Areas of concern: D/E (1/5), P/E (2/5), P/B (1/5).
Rating Change History
DateFromTo
2026-05-01 A- B+
2026-04-24 B+ A-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 67 Grade B
Profitability
88
Balance Sheet
41
Earnings Quality
67
Growth
74
Value
43
Momentum
91
Safety
50
Cash Flow
68
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. AMGN scores highest in Momentum (91/100) and lowest in Balance Sheet (41/100). A grade of B indicates above-average fundamentals with room for improvement in select areas.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
2.04
Grey Zone
Piotroski F-Score
8/9
✓ ✓ ✓ ✓ ✓ ✓ ✗ ✓ ✓
Beneish M-Score
-2.56
Unlikely Manipulator
Ohlson O-Score
-6.96
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
BB
Score: 44.0/100
Trend: Improving
Earnings Quality
100/100
OCF/NI: 1.43x
Accruals: -4.1%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. AMGN scores 2.04, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. AMGN scores 8/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. AMGN's score of -2.56 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. AMGN's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. AMGN receives an estimated rating of BB (score: 44.0/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). AMGN's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
27.53x
PEG
0.87x
P/S
6.33x
P/B
20.63x
P/FCF
19.25x
P/OCF
15.70x
EV/EBITDA
13.57x
EV/Revenue
6.27x
EV/EBIT
18.46x
EV/FCF
23.51x
Earnings Yield
4.46%
FCF Yield
5.20%
Shareholder Yield
2.70%
Graham Number
$88.14
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 27.5x earnings, AMGN commands a growth premium. Graham's intrinsic value formula yields $88.14 per share, 404% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.850
NI / EBT
×
Interest Burden
0.794
EBT / EBIT
×
EBIT Margin
0.340
EBIT / Rev
×
Asset Turnover
0.415
Rev / Assets
×
Equity Multiplier
9.601
Assets / Equity
=
ROE
91.5%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. AMGN's ROE of 91.5% is driven by financial leverage (equity multiplier: 9.60x). Note: high leverage means ROE is amplified by debt rather than operational performance.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
2.65%
Fair P/E
13.80x
Intrinsic Value
$221.82
Price/Value
1.62x
Margin of Safety
-62.31%
Premium
62.31%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with AMGN's realized 2.7% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. AMGN trades at a 62% premium to its adjusted intrinsic value of $221.82, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 13.8x compares to the current market P/E of 27.5x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$447.95
Median 1Y
$497.23
5th Pctile
$314.68
95th Pctile
$785.70
Ann. Volatility
26.3%
Analyst Target
$407.26
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Robert A. Bradway
Chief Executive Officer and President
$1,925,409 $12,599,589 $24,693,120
James E. Bradner
Executive Vice President, Research and Development
$1,238,580 $3,359,787 $8,639,867
Peter H. Griffith
Executive Vice President and Chief Financial Officer
$1,223,994 $3,709,745 $8,610,887
Murdo Gordon President,
Vice President, Global Commercial Operations
$1,233,189 $3,709,745 $8,523,471
David M. Reese
Executive Vice President and Chief Technology Officer
$1,306,721 $3,359,787 $8,290,308

CEO Pay Ratio

110:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $24,693,120
Avg Employee Cost (SGA/emp): $223,810
Employees: 31,500

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
31,500
+12.5% YoY
Revenue / Employee
$1,166,381
Rev: $36,741,000,000
Profit / Employee
$244,794
NI: $7,711,000,000
SGA / Employee
$223,810
Avg labor cost proxy
R&D / Employee
$221,397
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 58.5% 73.2% 1.1% 1.2% 1.2% 1.3% 2.5% 1.7% 1.3% 1.4% 72.6% 49.3% 55.7% 67.6% 1.1% 99.1% 81.7% 1.1% 1.0% 91.5% 91.47%
ROA 8.7% 9.5% 9.4% 11.0% 10.6% 10.4% 10.7% 10.7% 9.8% 8.3% 4.1% 3.5% 4.7% 4.3% 6.5% 7.4% 7.7% 8.5% 8.6% 9.5% 9.53%
ROIC 19.4% 21.0% 22.5% 25.9% 27.6% 25.6% 22.1% 24.2% 22.9% 11.3% 10.2% 9.3% 9.5% 11.9% 12.1% 13.1% 13.4% 16.3% 18.6% 19.5% 19.54%
ROCE 15.2% 16.1% 16.7% 18.7% 18.3% 17.7% 14.5% 15.4% 15.2% 13.6% 10.2% 9.7% 11.2% 11.3% 14.6% 15.4% 16.3% 18.0% 17.5% 18.5% 18.47%
Gross Margin 76.0% 74.9% 75.0% 77.1% 76.1% 74.5% 71.8% 74.0% 73.8% 62.0% 57.0% 61.4% 61.1% 65.7% 63.6% 67.2% 67.8% 81.9% 68.2% 72.0% 72.04%
Operating Margin 35.5% 33.7% 40.1% 33.0% 40.0% 32.6% 31.5% 38.4% 29.3% 15.5% 13.3% 22.8% 24.1% 25.4% 14.5% 28.8% 26.4% 39.8% 30.9% 35.0% 34.95%
Net Margin 28.1% 27.7% 23.7% 20.0% 32.2% 23.6% 46.5% 19.7% 25.1% 9.4% -1.5% 8.9% 33.3% 6.9% 21.2% 15.6% 33.7% 13.5% 21.1% 23.6% 23.62%
EBITDA Margin 49.2% 48.5% 45.1% 40.7% 54.1% 44.9% 80.0% 46.7% 52.2% 37.2% 28.9% 35.8% 62.0% 32.2% 50.1% 39.5% 61.9% 33.3% 44.8% 45.3% 45.29%
FCF Margin 30.4% 32.3% 32.0% 31.7% 34.2% 33.4% 28.8% 36.4% 35.0% 26.1% 24.0% 17.7% 19.3% 31.1% 32.0% 30.4% 32.1% 22.0% 23.1% 26.7% 26.69%
OCF Margin 33.4% 35.6% 35.4% 35.3% 37.5% 36.9% 32.9% 40.6% 39.4% 30.0% 27.4% 20.8% 22.3% 34.4% 35.7% 34.4% 36.5% 27.1% 28.9% 32.7% 32.73%
ROE 3Y Avg snapshot only 72.25%
ROE 5Y Avg snapshot only 1.21%
ROA 3Y Avg snapshot only 6.71%
ROIC 3Y Avg snapshot only 13.88%
ROIC Economic snapshot only 15.76%
Cash ROA snapshot only 13.05%
Cash ROIC snapshot only 22.69%
CROIC snapshot only 18.50%
NOPAT Margin snapshot only 28.20%
Pretax Margin snapshot only 26.98%
R&D / Revenue snapshot only 20.03%
SGA / Revenue snapshot only 18.37%
SBC / Revenue snapshot only 0.96%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 18.50 18.62 20.27 17.43 15.69 19.24 14.76 13.55 17.47 21.33 37.60 50.49 38.87 32.78 27.18 22.03 21.25 22.59 24.21 22.40 27.528
P/S Ratio 4.03 4.22 4.41 4.35 4.07 4.79 4.46 4.07 4.93 5.08 4.79 5.11 5.05 4.01 4.73 4.18 4.14 4.74 5.07 5.14 6.332
P/B Ratio 12.63 16.37 126.62 47.39 29.35 34.43 21.84 15.94 17.26 22.99 28.17 26.67 21.84 22.81 25.98 19.63 15.47 20.12 20.55 16.76 20.629
P/FCF 13.23 13.09 13.78 13.72 11.92 14.35 15.51 11.16 14.09 19.47 19.93 28.84 26.17 12.90 14.77 13.75 12.90 21.50 21.97 19.25 19.248
P/OCF 12.05 11.85 12.44 12.30 10.85 12.97 13.55 10.01 12.49 16.91 17.48 24.52 22.66 11.67 13.23 12.14 11.34 17.49 17.56 15.70 15.696
EV/EBITDA 11.62 11.95 13.15 11.88 10.83 12.79 10.31 9.14 10.65 13.31 16.22 17.90 16.01 13.64 13.73 12.20 11.73 12.99 14.03 13.57 13.572
EV/Revenue 4.98 5.20 5.56 5.46 5.11 5.91 5.61 5.09 5.88 6.99 6.63 6.83 6.63 5.45 6.15 5.56 5.39 5.97 6.29 6.27 6.273
EV/EBIT 16.83 17.09 18.93 16.46 14.85 17.79 13.64 12.01 14.07 18.35 26.10 31.38 27.29 23.47 21.62 18.69 17.46 18.70 19.86 18.46 18.461
EV/FCF 16.38 16.10 17.38 17.23 14.94 17.72 19.50 13.98 16.83 26.76 27.59 38.57 34.35 17.53 19.22 18.29 16.81 27.12 27.24 23.51 23.505
Earnings Yield 5.4% 5.4% 4.9% 5.7% 6.4% 5.2% 6.8% 7.4% 5.7% 4.7% 2.7% 2.0% 2.6% 3.1% 3.7% 4.5% 4.7% 4.4% 4.1% 4.5% 4.46%
FCF Yield 7.6% 7.6% 7.3% 7.3% 8.4% 7.0% 6.4% 9.0% 7.1% 5.1% 5.0% 3.5% 3.8% 7.8% 6.8% 7.3% 7.8% 4.7% 4.6% 5.2% 5.20%
PEG Ratio snapshot only 0.870
EV/OCF snapshot only 19.167
EV/Gross Profit snapshot only 8.635
Acquirers Multiple snapshot only 18.909
Shareholder Yield snapshot only 2.70%
Graham Number snapshot only $88.14
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 1.64 1.59 1.44 1.53 1.68 1.41 3.14 2.77 2.86 1.65 1.42 1.26 1.32 1.26 1.17 1.31 1.28 1.14 1.26 1.37 1.371
Quick Ratio 1.36 1.26 1.09 1.17 1.35 1.10 2.79 2.48 2.56 1.13 0.98 0.89 0.96 0.95 0.88 0.98 0.99 0.90 1.01 1.13 1.127
Debt/Equity 4.57 4.97 40.23 15.10 10.60 10.64 11.52 9.08 7.90 10.37 12.75 10.57 8.02 10.23 9.24 7.57 5.67 6.31 6.24 4.90 4.903
Net Debt/Equity 3.00 3.77 33.09 12.13 7.45 8.10 5.62 4.03 3.36 8.61 10.81 9.00 6.83 8.19 7.83 6.49 4.69 5.25 4.93 3.71 3.706
Debt/Assets 0.58 0.54 0.62 0.62 0.61 0.60 0.69 0.68 0.67 0.67 0.69 0.69 0.66 0.65 0.64 0.64 0.61 0.60 0.62 0.60 0.599
Debt/EBITDA 3.40 2.95 3.31 3.01 3.12 3.20 4.32 4.15 4.08 4.37 5.30 5.30 4.48 4.50 3.75 3.54 3.30 3.23 3.44 3.25 3.252
Net Debt/EBITDA 2.23 2.24 2.72 2.42 2.19 2.44 2.11 1.84 1.74 3.63 4.50 4.52 3.81 3.60 3.18 3.03 2.73 2.69 2.71 2.46 2.458
Interest Coverage 6.46 6.60 6.40 6.97 6.83 6.22 6.51 5.43 4.54 3.73 2.38 2.10 2.45 2.46 3.18 3.51 3.88 4.24 4.36 4.86 4.856
Equity Multiplier 7.91 9.13 64.62 24.51 17.44 17.79 16.59 13.31 11.83 15.59 18.51 15.34 12.07 15.63 14.40 11.83 9.37 10.46 10.07 8.18 8.183
Cash Ratio snapshot only 0.549
Debt Service Coverage snapshot only 6.605
Cash to Debt snapshot only 0.244
FCF to Debt snapshot only 0.178
Defensive Interval snapshot only 587.3 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.40 0.42 0.43 0.44 0.41 0.42 0.35 0.36 0.35 0.35 0.33 0.34 0.36 0.35 0.37 0.39 0.40 0.40 0.41 0.42 0.415
Inventory Turnover 1.56 1.62 1.55 1.48 1.43 1.42 1.39 1.44 1.45 1.17 1.45 1.75 2.08 1.56 1.63 1.70 1.78 1.64 1.65 1.63 1.629
Receivables Turnover 5.82 5.52 5.54 5.38 5.22 5.03 4.84 4.77 4.68 4.39 4.72 4.85 4.83 4.76 4.58 4.46 4.55 4.50 4.31 4.03 4.028
Payables Turnover 5.43 4.63 4.66 5.05 5.37 4.36 4.82 5.57 5.53 5.35 6.74 6.53 7.34 7.35 6.26 4.70 4.88 0.95 3.98 0.90 0.904
DSO 63 66 66 68 70 73 75 77 78 83 77 75 76 77 80 82 80 81 85 91 90.6 days
DIO 233 226 236 247 255 257 262 253 252 312 252 209 176 234 223 215 206 222 222 224 224.1 days
DPO 67 79 78 72 68 84 76 66 66 68 54 56 50 50 58 78 75 383 92 404 403.7 days
Cash Conversion Cycle 229 213 223 243 257 246 262 264 264 327 276 228 202 261 245 219 211 -80 215 -89 -89.0 days
Fixed Asset Turnover snapshot only 4.461
Operating Cycle snapshot only 314.7 days
Cash Velocity snapshot only 2.725
Capital Intensity snapshot only 2.509
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3.1% 2.2% 4.6% 3.5% 2.2% 1.3% -0.5% 0.8% 1.9% 7.1% 12.8% 16.4% 21.2% 18.6% 15.6% 12.8% 10.5% 10.0% 9.1% 9.2% 9.23%
Net Income -23.7% -18.9% -19.2% 14.4% 21.9% 11.2% 38.3% 21.3% 10.7% 2.5% -52.5% -60.8% -44.1% -39.1% 57.7% 1.1% 65.6% 88.5% 31.5% 32.1% 32.09%
EPS -21.2% -16.0% -14.8% 22.8% 29.1% 16.5% 41.7% 21.3% 10.7% 2.3% -52.3% -61.1% -44.5% -39.3% 56.2% 1.1% 65.6% 88.2% 30.7% 31.4% 31.36%
FCF -23.4% -15.2% -14.4% -6.1% 14.8% 4.8% -10.5% 15.9% 4.2% -16.2% -5.7% -43.4% -33.0% 41.2% 53.8% 93.5% 83.7% -22.1% -21.2% -4.1% -4.05%
EBITDA -14.5% -13.1% -12.5% 8.6% 12.4% 7.7% 28.0% 22.3% 19.4% 21.6% -15.2% -20.3% -9.0% -9.8% 26.6% 34.6% 22.7% 26.6% 9.2% 10.8% 10.84%
Op. Income -20.0% -16.4% -10.1% 26.2% 31.3% 25.2% 12.2% 1.5% -8.1% -17.4% -22.5% -34.8% -29.8% -8.1% 6.9% 32.1% 39.3% 41.8% 58.2% 54.6% 54.62%
OCF Growth snapshot only 3.87%
Asset Growth snapshot only 8.81%
Equity Growth snapshot only 57.35%
Debt Growth snapshot only 1.96%
Shares Change snapshot only 0.55%
Dividend Growth snapshot only 5.67%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 3.4% 3.0% 3.5% 3.8% 4.0% 4.1% 3.0% 3.0% 2.4% 3.5% 5.5% 6.7% 8.1% 8.8% 9.0% 9.8% 10.9% 11.8% 12.4% 12.8% 12.77%
Revenue 5Y 2.7% 2.5% 2.8% 2.7% 2.7% 2.9% 2.7% 2.8% 2.8% 3.5% 4.5% 5.6% 6.8% 7.4% 7.3% 7.5% 7.6% 7.7% 8.2% 8.4% 8.39%
EPS 3Y 42.6% -7.4% -7.0% -2.1% -1.8% -2.5% 4.4% 6.4% 4.1% 0.1% -16.8% -16.6% -7.4% -10.2% 1.8% -0.0% 0.6% 5.3% -0.9% 2.7% 2.65%
EPS 5Y -0.5% 0.2% -0.5% 2.0% 2.6% 34.8% 36.4% 32.9% 32.9% -1.1% -11.5% -15.0% -10.2% -10.5% -3.2% -0.2% 0.7% 2.7% 3.3% 10.0% 10.01%
Net Income 3Y 36.6% -11.1% -10.8% -6.2% -5.4% -5.8% 1.0% 3.0% 1.0% -2.6% -19.0% -18.3% -9.0% -11.5% 1.2% 0.2% 0.8% 5.6% -0.5% 3.1% 3.09%
Net Income 5Y -5.9% -5.3% -6.2% -4.3% -3.5% 27.1% 29.0% 27.5% 28.0% -4.4% -14.2% -17.0% -12.1% -12.2% -5.0% -1.9% -1.0% 1.2% 1.9% 8.8% 8.76%
EBITDA 3Y -4.9% -4.3% -4.1% -1.1% -0.7% -1.2% 3.8% 5.5% 4.7% 4.4% -1.7% 1.9% 6.9% 5.7% 11.2% 9.5% 10.0% 11.6% 5.4% 5.9% 5.95%
EBITDA 5Y -1.8% -2.0% -2.7% -1.6% -1.0% -1.1% 1.9% 2.5% 2.9% 2.8% -0.9% -1.2% 1.2% 1.1% 3.7% 4.8% 5.1% 5.4% 5.6% 9.6% 9.58%
Gross Profit 3Y 0.3% -0.2% 0.4% 1.1% 1.3% 1.6% 0.8% 1.2% 1.0% 0.8% 1.0% 0.7% 0.4% 1.7% 2.8% 4.0% 6.0% 9.2% 10.7% 12.0% 12.00%
Gross Profit 5Y 1.1% 0.7% 1.0% 1.1% 1.1% 1.2% 0.7% 0.6% 0.5% 0.1% 0.1% 0.2% 0.5% 1.6% 2.3% 3.4% 4.4% 6.1% 6.9% 7.6% 7.61%
Op. Income 3Y -10.2% -9.4% -7.2% -1.7% -1.2% -0.4% -2.0% 1.1% -1.2% -4.8% -7.9% -5.8% -5.4% -1.7% -2.4% -4.4% -3.5% 2.5% 9.4% 10.0% 10.03%
Op. Income 5Y -4.7% -4.8% -4.3% -1.9% -1.1% -0.8% -2.3% -1.5% -2.6% -5.1% -7.0% -8.9% -9.1% -5.6% -4.9% -2.3% -1.2% 2.4% 5.7% 11.3% 11.26%
FCF 3Y -9.1% -7.4% -4.7% -2.7% -0.7% 1.0% -5.0% -1.7% -2.9% -9.4% -10.3% -14.9% -7.1% 7.4% 9.0% 8.3% 8.6% -2.7% 4.5% 1.7% 1.66%
FCF 5Y -1.8% -2.5% -3.3% -3.0% -2.9% -3.5% -7.1% -1.9% -2.1% -7.0% -6.1% -9.6% -7.3% 4.0% 4.4% 0.8% 2.4% -3.9% -2.7% 2.7% 2.72%
OCF 3Y -8.2% -6.4% -3.6% -1.4% 0.2% 2.0% -3.0% -0.2% -0.9% -6.9% -8.2% -12.3% -5.5% 7.5% 9.4% 8.8% 9.9% 0.8% 7.7% 4.9% 4.93%
OCF 5Y -1.6% -2.2% -2.9% -2.3% -2.6% -2.8% -5.6% -0.9% -1.0% -5.6% -4.9% -7.9% -5.9% 4.7% 5.3% 2.0% 3.9% -1.0% 0.5% 5.5% 5.48%
Assets 3Y -1.2% -2.7% -2.6% -0.0% 2.3% 2.9% 12.9% 11.6% 11.9% 15.6% 14.1% 15.0% 11.8% 14.5% 14.7% 14.0% 12.3% 11.6% 1.4% 1.9% 1.94%
Assets 5Y -3.6% -4.7% -5.3% -5.7% -4.5% -4.0% 4.5% 5.9% 6.1% 7.9% 7.8% 8.9% 8.8% 9.0% 7.7% 6.2% 6.9% 7.6% 8.1% 9.9% 9.86%
Equity 3Y -17.0% -18.8% -56.1% -39.3% -30.6% -27.7% -17.4% -14.0% -11.3% -12.8% -18.7% -10.4% -2.9% -4.3% 89.2% 45.3% 38.1% 33.2% 19.8% 19.9% 19.90%
Book Value 3Y -13.3% -15.3% -54.2% -36.6% -27.9% -25.1% -14.6% -11.2% -8.5% -10.5% -16.5% -8.5% -1.2% -2.9% 90.4% 45.0% 37.7% 32.9% 19.3% 19.4% 19.38%
Dividend 3Y 6.9% 6.6% 6.6% 6.2% 5.5% 5.1% 4.8% 5.3% 5.6% 5.6% 5.7% 4.7% 4.0% 3.4% 2.6% 1.7% 1.7% 1.7% 1.6% 1.6% 1.60%
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.88 0.78 0.90 0.92 0.92 0.90 0.94 0.97 0.99 0.94 0.84 0.82 0.78 0.84 0.83 0.84 0.81 0.84 0.89 0.90 0.903
Earnings Stability 0.02 0.02 0.01 0.00 0.00 0.12 0.25 0.32 0.28 0.64 0.50 0.38 0.42 0.65 0.32 0.10 0.05 0.02 0.00 0.08 0.079
Margin Stability 0.96 0.95 0.96 0.96 0.96 0.96 0.96 0.96 0.96 0.94 0.92 0.91 0.89 0.90 0.90 0.90 0.90 0.92 0.92 0.92 0.919
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 0.00 1.00 1.00 1.00 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.91 0.92 0.92 0.94 0.91 0.96 0.85 0.91 0.96 0.99 0.50 0.50 0.82 0.84 0.50 0.50 0.50 0.50 0.87 0.87 0.872
Earnings Smoothness 0.73 0.79 0.79 0.87 0.80 0.89 0.68 0.81 0.90 0.98 0.29 0.13 0.43 0.51 0.55 0.28 0.51 0.39 0.73 0.72 0.723
ROE Trend -0.02 0.09 5.46 2.03 1.19 0.96 -2.02 -0.53 -0.29 -0.26 -3.11 -1.42 -0.87 -0.74 -0.16 0.04 -0.05 0.00 -0.00 0.04 0.038
Gross Margin Trend -0.04 -0.03 -0.03 -0.01 -0.00 0.00 -0.00 -0.01 -0.02 -0.05 -0.09 -0.12 -0.14 -0.11 -0.08 -0.04 -0.01 0.05 0.07 0.09 0.088
FCF Margin Trend -0.10 -0.05 -0.06 -0.07 -0.02 -0.02 -0.07 0.03 0.03 -0.07 -0.06 -0.16 -0.15 0.01 0.06 0.03 0.05 -0.07 -0.05 0.03 0.026
Sustainable Growth Rate 17.3% 23.3% 32.1% 46.3% 45.3% 45.5% 1.2% 78.8% 55.0% 43.7% -16.7% -24.7% -7.1% -12.3% 18.3% 24.6% 22.9% 35.6% 33.7% 36.2% 36.18%
Internal Growth Rate 2.6% 3.1% 2.8% 4.3% 4.4% 3.9% 5.2% 5.1% 4.2% 2.7% — — — — 1.1% 1.9% 2.2% 2.9% 2.9% 3.9% 3.92%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 1.53 1.57 1.63 1.42 1.45 1.48 1.09 1.35 1.40 1.26 2.15 2.06 1.72 2.81 2.05 1.81 1.87 1.29 1.38 1.43 1.427
FCF/OCF 0.91 0.90 0.90 0.90 0.91 0.90 0.87 0.90 0.89 0.87 0.88 0.85 0.87 0.90 0.90 0.88 0.88 0.81 0.80 0.82 0.815
FCF/Net Income snapshot only 1.164
OCF/EBITDA snapshot only 0.708
CapEx/Revenue 3.0% 3.4% 3.4% 3.7% 3.4% 3.6% 4.2% 4.2% 4.5% 3.9% 3.4% 3.1% 3.0% 3.3% 3.7% 4.0% 4.4% 5.1% 5.8% 6.0% 6.04%
CapEx/Depreciation snapshot only 0.493
Accruals Ratio -0.05 -0.05 -0.06 -0.05 -0.05 -0.05 -0.01 -0.04 -0.04 -0.02 -0.05 -0.04 -0.03 -0.08 -0.07 -0.06 -0.07 -0.02 -0.03 -0.04 -0.041
Sloan Accruals snapshot only -0.016
Cash Flow Adequacy snapshot only 1.644
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 3.8% 3.7% 3.5% 3.6% 3.9% 3.3% 3.6% 4.0% 3.4% 3.2% 3.3% 3.0% 2.9% 3.6% 3.0% 3.4% 3.4% 2.9% 2.8% 2.7% 2.23%
Dividend/Share $6.94 $7.10 $7.40 $7.65 $7.71 $7.78 $7.91 $8.11 $8.28 $8.44 $8.63 $8.68 $8.80 $8.92 $9.06 $9.19 $9.31 $9.44 $9.56 $9.72 $9.94
Payout Ratio 70.5% 68.1% 71.2% 62.5% 60.7% 64.0% 53.7% 54.6% 58.9% 67.8% 1.2% 1.5% 1.1% 1.2% 82.6% 75.1% 72.0% 66.5% 66.7% 60.4% 60.45%
FCF Payout Ratio 50.4% 47.9% 48.4% 49.2% 46.1% 47.8% 56.5% 45.0% 47.5% 61.9% 65.2% 85.7% 75.9% 46.5% 44.9% 46.9% 43.7% 63.3% 60.5% 51.9% 51.94%
Total Payout Ratio 1.5% 1.5% 2.5% 2.0% 1.7% 1.6% 53.7% 54.6% 58.9% 67.8% 1.2% 1.5% 1.1% 1.2% 86.0% 78.2% 74.9% 66.5% 66.7% 60.4% 60.45%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Chowder Number 0.11 0.11 0.10 0.09 0.09 0.08 0.08 0.10 0.11 0.12 0.12 0.11 0.10 0.10 0.09 0.09 0.09 0.09 0.09 0.09 0.090
Buyback Yield 4.6% 4.5% 9.0% 7.7% 7.3% 5.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.1% 0.1% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield 4.6% 4.5% 9.0% 7.7% 7.3% 5.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.1% 0.1% 0.0% 0.0% 0.0% 0.00%
Total Shareholder Return 8.4% 8.2% 12.5% 11.3% 11.1% 8.4% 3.6% 4.0% 3.4% 3.2% 3.3% 3.0% 2.9% 3.8% 3.2% 3.5% 3.5% 2.9% 2.8% 2.7% 2.70%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.87 0.88 0.88 0.88 0.88 0.89 0.87 0.87 0.86 0.86 0.87 0.89 0.90 0.89 0.89 0.89 0.85 0.86 0.86 0.85 0.850
Interest Burden (EBT/EBIT) 0.85 0.85 0.84 0.86 0.85 0.84 0.85 0.82 0.78 0.73 0.58 0.52 0.59 0.59 0.69 0.72 0.74 0.76 0.77 0.79 0.794
EBIT Margin 0.30 0.30 0.29 0.33 0.34 0.33 0.41 0.42 0.42 0.38 0.25 0.22 0.24 0.23 0.28 0.30 0.31 0.32 0.32 0.34 0.340
Asset Turnover 0.40 0.42 0.43 0.44 0.41 0.42 0.35 0.36 0.35 0.35 0.33 0.34 0.36 0.35 0.37 0.39 0.40 0.40 0.41 0.42 0.415
Equity Multiplier 6.76 7.70 11.88 11.16 10.84 12.19 23.61 16.26 13.64 16.40 17.52 14.26 11.95 15.61 16.24 13.39 10.56 12.55 11.81 9.60 9.601
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $9.84 $10.43 $10.39 $12.25 $12.70 $12.16 $14.72 $14.86 $14.06 $12.44 $7.02 $5.79 $7.80 $7.55 $10.97 $12.23 $12.92 $14.20 $14.34 $16.07 $16.07
Book Value/Share $14.42 $11.86 $1.66 $4.50 $6.79 $6.79 $9.94 $12.63 $14.23 $11.54 $9.37 $10.95 $13.89 $10.84 $11.47 $13.73 $17.75 $15.94 $16.89 $21.49 $21.64
Tangible Book/Share $-37.03 $-41.37 $-51.81 $-49.11 $-45.46 $-51.85 $-47.54 $-43.54 $-39.04 $-83.40 $-83.81 $-79.23 $-73.89 $-74.65 $-70.54 $-66.28 $-59.40 $-59.48 $-56.73 $-50.49 $-50.49
Revenue/Share $45.21 $45.98 $47.76 $49.13 $48.94 $48.84 $48.68 $49.50 $49.88 $52.20 $55.10 $57.18 $60.03 $61.67 $63.08 $64.52 $66.35 $67.71 $68.45 $70.08 $70.60
FCF/Share $13.75 $14.83 $15.28 $15.56 $16.72 $16.30 $14.00 $18.04 $17.43 $13.63 $13.24 $10.13 $11.59 $19.18 $20.18 $19.60 $21.29 $14.92 $15.80 $18.70 $18.84
OCF/Share $15.10 $16.39 $16.92 $17.36 $18.36 $18.04 $16.02 $20.11 $19.67 $15.69 $15.10 $11.91 $13.39 $21.20 $22.54 $22.21 $24.22 $18.34 $19.77 $22.94 $23.11
Cash/Share $22.67 $14.22 $11.88 $13.38 $21.33 $17.26 $58.66 $63.78 $64.57 $20.27 $18.11 $17.19 $16.63 $22.09 $16.28 $14.84 $17.43 $16.81 $22.13 $25.72 $25.91
EBITDA/Share $19.38 $19.99 $20.19 $22.56 $23.07 $22.58 $26.47 $27.59 $27.55 $27.41 $22.52 $21.83 $24.88 $24.64 $28.25 $29.39 $30.51 $31.15 $30.67 $32.39 $32.39
Debt/Share $65.93 $58.95 $66.89 $68.01 $71.94 $72.25 $114.49 $114.61 $112.39 $119.65 $119.44 $115.79 $111.44 $110.88 $106.06 $103.89 $100.71 $100.56 $105.37 $105.34 $105.34
Net Debt/Share $43.26 $44.73 $55.01 $54.64 $50.61 $54.99 $55.83 $50.83 $47.82 $99.39 $101.33 $98.60 $94.81 $88.79 $89.78 $89.05 $83.29 $83.75 $83.24 $79.62 $79.62
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 2.038
Altman Z-Prime snapshot only 3.249
Piotroski F-Score 6 5 6 8 8 5 6 5 5 4 6 4 5 6 7 9 8 7 8 8 8
Beneish M-Score -2.56 -2.43 -2.63 -2.54 -2.61 -2.63 -2.38 -2.51 -2.49 -2.14 -2.22 -2.18 -2.11 -2.91 -2.68 -2.59 -2.72 -2.47 -2.56 -2.56 -2.557
Ohlson O-Score snapshot only -6.964
Net-Net WC snapshot only $-90.06
EVA snapshot only $5249331962.67
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BB
Credit Score 47.54 48.06 46.97 48.14 47.97 47.12 49.74 46.86 43.95 37.88 32.18 30.31 32.16 31.97 36.04 37.16 38.29 40.99 43.21 43.96 43.957
Credit Grade snapshot only 12
Credit Trend snapshot only 6.799
Implied Spread (bps) snapshot only 475.000
Industry Credit Rank snapshot only 19
Sector Credit Rank snapshot only 43

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms